Barcelona Liver Bioservices announces collaboration with Inventiva

Barcelona Liver Bioservices, CRO specialized in the design and development of pre-clinical studies in hepatology, announced today a non-exclusive collaboration with Inventiva, a clinical stage biopharmaceutical company with expertise in fibrosis, oncology and orphan diseases.

Under the terms of the agreement, which combines the scientific and technical expertise of both companies, BLB will perform cutting-edge research to understand the mechanisms underlying the beneficial effects of Inventiva’s lead compound lanifibranor on liver cirrhosis and portal hypertension. The research plan incorporates different BLB’s models of liver disease, including the unique ExoLiver® platform, to obtain consistent pre-clinical data.

For more information about the services and research developed by BLB please visit www.liver.barcelona

More News.

Barcelona Liver Bioservices (BLB) starts operations

Barcelona Liver Bioservices (BLB), a spin-off of IDIBAPS, has been created for the design and development of pre-clinical studies in the fields of hepatology and hepatotoxicity. The co-founders are Jordi Gracia-Sancho, Jaume Bosch and Joan Carles Garcia-Pagan from IDIBAPS and Rosa Villa from CSIC.

Read More »